Quetiapine and citalopram: Aetiological significance in serotonin syndrome

New Zealand Medical Journal

Volumn 119, Issue 1237, 2006, Pages

  Marlowe, Karl ^a   Schirgel, Dorothea ^b  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b CANTERBURY DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; QUETIAPINE; RISPERIDONE; ANXIOLYTIC AGENT; DIBENZOTHIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGITATION; ARTICLE; BIPOLAR DISORDER; CASE REPORT; DEHYDRATION; DELIRIUM; DISORIENTATION; DRUG DOSE REDUCTION; FEMALE; FLUID THERAPY; FOLLOW UP; HUMAN; HYPERREFLEXIA; LOW DRUG DOSE; MAINTENANCE THERAPY; MANIC DEPRESSIVE PSYCHOSIS; MUSCLE RIGIDITY; PATHOPHYSIOLOGY; REMISSION; SEROTONIN SYNDROME; SIDE EFFECT; URINE INCONTINENCE; CHEMICALLY INDUCED DISORDER; DRUG COMBINATION; TREATMENT OUTCOME;

ADULT; ALPRAZOLAM; ANTI-ANXIETY AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CITALOPRAM; DIBENZOTHIAZEPINES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; RISPERIDONE; SEROTONIN ANTAGONISTS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 33746341528     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Duggal HS, Fetchko J. Serotonin syndrome and atypical antipsychotics. Am J Psychiatry. 2002;159:672-3.
2. Osei-Owusu P, James A, Crane J, et al. 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. J Pharmacol Exp Ther. 2005;313:1324-30.
3. Birmes P, Coppin D, Schmitt L, et al. Serotonin syndrome: a brief review. Can Med Assoc J. 2003;168:1439-42.
4. Voirol P, Hodel P-F, Zullino D, et al. Serotonin syndrome after small doses of citalopram or sertraline. J Clin Psychopharmacol. 2002;20:713-4.
5. Isbister GK, Downes F, Whyte IM. Olanzapine and serotonin toxicity. Psychiatry Clin Neurosci. 2003;57:241-2.
6. Kinzie E, Meltzer-Brody S. Possible serotonin syndrome with citalopram following cross-titration of clozapine to ziprasidone. Gen Hosp Psychiatry. 2005;27:223-4.
7. Radomski JW, Dursun SM, Reveley MA, et al. An exploratory approach to the serotonin syndrome: an update of clinical phenomenology and revised diagnostic criteria. Med Hypotheses. 2000;55:218-24.
8. Dunkley EJ, Isbister GK, Sibbritt D, et al. The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity. QJM. 2003;96:635-42.
9. Gardner DM, Baldessarini RJ, Waraich P. Modern antipsychotic drugs: a critical overview. Can Med Assoc J. 2005;172:1703-11.
10. Boyer EW, Shannon M. Current concepts: The serotonin syndrome. N Engl J Med. 2005;352:1112-20.